PF-05231023
Names
[ CAS No. ]:
1037589-69-7
[ Name ]:
PF-05231023
Biological Activity
[Description]:
PF-05231023, a long-acting fibroblast growth factor 21 (FGF21) analog, is a FGF21-receptor agonist, suitable for development as a potential treatment for T2DM[1][5].
[Related Catalog]:
[Target]
FGF21-receptor[5].
[In Vitro]
PF-05231023 is a long-acting fibroblast growth factor 21 (FGF21) analog[2].
[In Vivo]
Administration of native FGF21 and PF-05231023 ( 3 mg/kg or 10 mg/kg ) improves glucose tolerance and liver insulin sensitivity in Zucker rats[3]. PF-05231023 (10 mg/kg) shows protective effects on Akita retinas. PF-05231023 (10 mg/kg) decreases retinal inflammation in diabetic mice. PF-05231023 (10 mg/kg) administration reduces retinal IL-1β mRNA expression in Akita mice. PF-05231023 (10 mg/kg) administration increases cone-specific arrestin4 expression in Akita mice. PF-05231023 (10 mg/kg) administration restores photoreceptor morphology in Akita mice. PF-05231023 (10 mg/kg) inhibits oxidative-stress-induced inflammation in photoreceptors. PF-05231023 (10 mg/kg) administration decreases the variability of retinal NRF2 levels and shows a trend (non-significant) towards increased NRF2 levels in Akita mice[4].
[References]
[Related Small Molecules]
Chemical & Physical Properties
[ Molecular Formula ]:
C26H32N4O8
[ Molecular Weight ]:
528.55
[ Storage condition ]:
2-8℃